These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21351586)

  • 1. [The correlation of asymmetrical dimethylarginine level and oxidative stress to the onset of Alzheimer's disease].
    Chen M; Jiang P; Lü J; Xiang ZH; Jiao BH
    Yao Xue Xue Bao; 2010 Aug; 45(8):1001-5. PubMed ID: 21351586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.
    Arlt S; Schulze F; Eichenlaub M; Maas R; Lehmbeck JT; Schwedhelm E; Jahn H; Böger RH
    Dement Geriatr Cogn Disord; 2008; 26(1):58-64. PubMed ID: 18617736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid.
    Mulder C; Wahlund LO; Blomberg M; de Jong S; van Kamp GJ; Scheltens P; Teerlink T
    J Neural Transm (Vienna); 2002 Sep; 109(9):1203-8. PubMed ID: 12203047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
    Abe T; Tohgi H; Murata T; Isobe C; Sato C
    Neurosci Lett; 2001 Oct; 312(3):177-9. PubMed ID: 11602339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
    Luo Y; Yue W; Quan X; Wang Y; Zhao B; Lu Z
    Free Radic Biol Med; 2015 Feb; 79():117-26. PubMed ID: 25499850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
    Arlt S; Schwedhelm E; Kölsch H; Jahn H; Linnebank M; Smulders Y; Jessen F; Böger RH; Popp J
    J Alzheimers Dis; 2012; 31(4):751-8. PubMed ID: 22710910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells.
    Wells SM; Holian A
    Am J Respir Cell Mol Biol; 2007 May; 36(5):520-8. PubMed ID: 17158357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease.
    Santos AN; Ewers M; Minthon L; Simm A; Silber RE; Blennow K; Prvulovic D; Hansson O; Hampel H
    J Alzheimers Dis; 2012; 29(1):171-6. PubMed ID: 22214781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
    Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
    J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.
    Wang SW; Wang YJ; Su YJ; Zhou WW; Yang SG; Zhang R; Zhao M; Li YN; Zhang ZP; Zhan DW; Liu RT
    Neurotoxicology; 2012 Jun; 33(3):482-90. PubMed ID: 22445961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis.
    Isobe C; Abe T; Terayama Y
    Neurosignals; 2010; 18(1):43-8. PubMed ID: 20407287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.
    Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M
    J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM
    J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Cini C; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):418-26. PubMed ID: 16634068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.